Evidence map›Paper›PMID 38272862›Full record

Observational studyTranslational psychiatry2024

Development and multi-site external validation of a generalizable risk prediction model for bipolar disorder.

Colin G Walsh, Michael A Ripperger, Yirui Hu, Yi-Han Sheu, Hyunjoon Lee, Drew Wilimitis, Amanda B Zheutlin, Daniel Rocha, Karmel W Choi, Victor M Castro and 4 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Big data and psychiatry: advances, constraints and future directions.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  2. Article
  3. Prediction of early-onset bipolar using electronic health records.Journal of child psychology and psychiatry, and allied disciplines · 2025
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Colin G WalshVanderbilt University Medical Center Health System, Nashville, TN, USA. Colin.walsh@vumc.org.ORCID 0000-0002-9379-2056
Michael A RippergerVanderbilt University Medical Center Health System, Nashville, TN, USA.ORCID 0000-0002-9613-346X
Yirui HuGeisinger Health System, Danville, PA, USA.
Yi-Han SheuMassachusetts General-Brigham Health System, Boston, MA, USA.ORCID 0000-0002-2767-0851
Hyunjoon LeeVanderbilt University Medical Center Health System, Nashville, TN, USA.
Drew WilimitisVanderbilt University Medical Center Health System, Nashville, TN, USA.
Amanda B ZheutlinMassachusetts General-Brigham Health System, Boston, MA, USA.
Daniel RochaGeisinger Health System, Danville, PA, USA.
Karmel W ChoiMassachusetts General-Brigham Health System, Boston, MA, USA.
Victor M CastroMassachusetts General-Brigham Health System, Boston, MA, USA.ORCID 0000-0001-7390-6354
H Lester KirchnerGeisinger Health System, Danville, PA, USA.
Christopher F ChabrisGeisinger Health System, Danville, PA, USA.
Lea K DavisVanderbilt University Medical Center Health System, Nashville, TN, USA.
Jordan W SmollerMassachusetts General-Brigham Health System, Boston, MA, USA.
Vanderbilt University Medical Center · USGeisinger Health System · USMass General Brigham · USMassachusetts General Hospital · US

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
PsycheMERGE: Leveraging electronic health records and genomics for mental health researchR01MH118233 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DAVIS, LEA K, SMOLLER, JORDAN W · 2019 to 2022
$3.1M
Distinguishing Clinical and Genetic Risk of Suicidal Ideation from Attempts to Inform PreventionR01MH121455 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RUDERFER, DOUGLAS, WALSH, COLIN GEORGE · 2020 to 2024
$2.7M
2/7 PsycheMERGE: Advancing Precision PsychiatryR01MH137218 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI JORDAN W SMOLLER · 2024 to 2026
$2.4M
7/7-PsycheMERGE: Advancing Precision PsychiatryR01MH137191 · NIMH · GEISINGER CLINIC · PI Christopher F. Chabris · 2024 to 2026
$2.4M
1/7-PsycheMERGE: Advancing Precision PsychiatryR01MH137220 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Lea K Davis · 2024 to 2026
$1.8M
2/2 Leveraging electronic health records for pharmacogenomics of psychiatric diordersR01MH116269 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RUDERFER, DOUGLAS, WALSH, COLIN GEORGE · 2019 to 2022
$1.7M
Mental health and chronic disease: A psycheMERGE investigation into the shared biology underlying psychiatric disorders and their physical comorbiditiesR56MH120736 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIS, LEA K · 2019 to 2020
$1.6M
Integrating Health Records, Genomic, and Social Data to Stratify Adolescent Depression RiskK08MH127413 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, KARMEL · 2021 to 2025
$987k
NICHD NIH HHS P50 HD103537NIMH NIH HHS K08 MH127413NIMH NIH HHS R01 MH116269NIMH NIH HHS R01 MH118233NIMH NIH HHS R01 MH121455NIMH NIH HHS R01 MH137191NIMH NIH HHS R01 MH137218NIMH NIH HHS R01 MH137220NIMH NIH HHS R56 MH120736
6 · The paper itself

Abstract

Bipolar disorder is a leading contributor to disability, premature mortality, and suicide. Early identification of risk for bipolar disorder using generalizable predictive models trained on diverse cohorts around the United States could improve targeted assessment of high risk individuals, reduce misdiagnosis, and improve the allocation of limited mental health resources. This observational case-control study intended to develop and validate generalizable predictive models of bipolar disorder as part of the multisite, multinational PsycheMERGE Network across diverse and large biobanks with linked electronic health records (EHRs) from three academic medical centers: in the Northeast (Massachusetts General Brigham), the Mid-Atlantic (Geisinger) and the Mid-South (Vanderbilt University Medical Center). Predictive models were developed and valid with multiple algorithms at each study site: random forests, gradient boosting machines, penalized regression, including stacked ensemble learning algorithms combining them. Predictors were limited to widely available EHR-based features agnostic to a common data model including demographics, diagnostic codes, and medications. The main study outcome was bipolar disorder diagnosis as defined by the International Cohort Collection for Bipolar Disorder, 2015. In total, the study included records for 3,529,569 patients including 12,533 cases (0.3%) of bipolar disorder. After internal and external validation, algorithms demonstrated optimal performance in their respective development sites. The stacked ensemble achieved the best combination of overall discrimination (AUC = 0.82-0.87) and calibration performance with positive predictive values above 5% in the highest risk quantiles at all three study sites. In conclusion, generalizable predictive models of risk for bipolar disorder can be feasibly developed across diverse sites to enable precision medicine. Comparison of a range of machine learning methods indicated that an ensemble approach provides the best performance overall but required local retraining. These models will be disseminated via the PsycheMERGE Network website.

Indexed as

Bipolar DisorderCase-Control StudiesElectronic Health RecordsHumansMachine LearningRisk Assessment

Identifiers

PMID38272862
PMCPMC10810911
OpenAlexW4391229876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.